Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00776529
Other study ID # BA06-01
Secondary ID
Status Completed
Phase Phase 1
First received October 20, 2008
Last updated January 28, 2009
Start date October 2008
Est. completion date December 2008

Study information

Verified date January 2009
Source University of Applied Sciences of Western Switzerland
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

AIM:

Strengthening and sensorimotor training (e.g with the aim to improve balance) are widely used in rehabilitation. There is little knowledge about the best ways to combine strengthening and sensorimotor training. Therefore, the investigators want to evaluate two types of combinations in healthy participants.

Interventions:

- Group A: 1.) warm-up; 2.) sensorimotor training; 3.) strength training (nine sessions in four weeks)

- Group B: 1.) warm-up; 2.) one strengthening exercise, followed by a sensorimotor exercise, alternating (nine sessions in four weeks)

Tests (Before first training and after four weeks):

- isokinetic test of knee extensors and flexors (60°/s; 120°/s; 180°/s; 240°/s.)

- squat jumps and countermovement jumps

- static balance test on an unstable underground (measured with accelerometer)

- dynamic balance: star excursion balance test, (a) on stable ground, (b) on unstable ground. Balance tests will be performed (c) in recovered state and (d) fatigue (i.e. after a fatiguing exercise).

Hypotheses

1. Group B (alternating sensorimotor and strength exercises) will improve more in the balance tests than Group A (sensorimotor first, strength afterwards).

2. Group B will improve more in the countermovement jump than Group A.

3. There will be no differences in the improvements in the strength, power and squat jump tests between the two groups.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Able to perform strength and sensorimotor training

- At least 18 years old

Exclusion Criteria:

- Injury that does not allow training and testing

- Illness that does not allow training and testing

- Pregnancy

- Pain during exercising

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Sensorimotor training first, followed by strength exercises
nine sessions of one hour duration
Strength exercises and sensorimotor exercises alternated
nine sessions of one hour

Locations

Country Name City State
Switzerland School of Physiotherapy, University of Applied Sciences Western Switzerland, Valais Leukerbad Valais

Sponsors (1)

Lead Sponsor Collaborator
University of Applied Sciences of Western Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Dynamic Balance measured with the Star Excursion Balance Test From baseline to four weeks No
Secondary Change in height with counter-movement jump From baseline to four weeks No
Secondary Change in height with squat jump From baseline to four weeks No
Secondary Change in force development (Nm) in knee extensors and knee flexors From baseline to four weeks No
Secondary Change in Power knee extensors and knee flexors From baseline to four weeks No
Secondary Change in Static Balance (single leg stance on unstable ground) From baseline to four weeks No
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1